Standout Papers
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study (2003)
- Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial (2005)
- OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study (2006)
- Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2 (2010)
Immediate Impact
9 from Science/Nature 82 standout
Citing Papers
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Dietary methionine influences therapy in mouse cancer models and alters human metabolism
2019 StandoutNature
Works of Gérard Lledo being referenced
Modified (m)Folfox7/bevacizumab (B) or modified (m)Xelox/bevacizumab with or without erlotinib (E) in first-line metastatic colorectal cancer (MCRC): Results of the feasibility phase of the DREAM-OPTIMOX3 study (GERCOR)
2007
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
2003 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gérard Lledo | 5683 | 2235 | 1618 | 100 | 6.3k | |
| Stephen K. Williamson | 3917 | 1885 | 1274 | 147 | 5.9k | |
| Javier Sastre | 4730 | 1855 | 1179 | 173 | 6.5k | |
| Emmanuel Mitry | 5043 | 2800 | 1166 | 126 | 6.6k | |
| Michelle R. Mahoney | 3301 | 1667 | 1131 | 71 | 4.7k | |
| Philippe Rougier | 3877 | 2326 | 2061 | 94 | 6.6k | |
| Guy van Hazel | 3659 | 1769 | 925 | 66 | 5.1k | |
| Claus‐Henning Köhne | 3069 | 1173 | 735 | 73 | 4.2k | |
| Yuxian Bai | 3050 | 2192 | 1150 | 181 | 5.7k | |
| Côme Lepage | 3384 | 1420 | 1691 | 208 | 5.1k | |
| Allen Lee Cohn | 4629 | 2314 | 837 | 158 | 6.7k |
All Works
Loading papers...